Trial Profile
A double-Blind, placebo-controlled, parallel group study to assess the efficacy, and safety of oral frovatriptan in the prevention on menstrually-related migraine (MRM) headaches in a `difficult to treat' population
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary)
- Indications Menstrual migraine
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 21 Jul 2007 New trial record.